Region: France
Category: Radiopharmaceuticals
Category: Radiopharmaceuticals
France Radiopharmaceuticals
(2 reports matching your criteria)
-
Europe Nuclear Medicine Market, By Type (Diagnostic (SPECT, PET)), Therapeutic (Beta Emitters, Alpha Emitters))); By Application (Diagnostic (SPECT, PET)), Therapeutic (Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Others)); By Procedural Volumes (Diagnostic (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals)), Therapeutic (Beta Emitters, Alpha Emitters, Brachytherapy)); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 Europe Nuclear Medicine Market Size almost Doubles at Robust CAGR of 12.03% during 2023–2029, ... Read More
-
France Radiopharmaceuticals Market By Radioisotope (Technetium 99m, Fluorine 18, Iodine I, Gallium 68, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals and clinics, Medical Imaging centers, Others): Opportunity Analysis and Industry Forecast, 2023-2032
... and Industry Forecast, 2023-2032 The France Radiopharmaceuticals Market is a quickly expanding, specialized company with an estimated market value of EUR8.4 billion in 2020. Radiopharmaceuticals are drugs which contain radioactive aspects and have both analysis ... Read More
Research Assistance
